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Summary 
 Intravenous glucagon cures fatty liver by improving 
glucose bioavailability in early lactation. Amino acids, 
which would be otherwise used for milk protein synthesis, 
are metabolized to glucose. The objective of this study was 
to examine whether intravenous glucagon and fatty liver 
change milk protein and amino acid composition in dairy 
cows. Multiparous Holstein cows (n=25) were designated as 
either normal or susceptible to fatty liver and ketosis as 
based on the ratio of liver triacylglycerol to glycogen being 
smaller or greater than 2.0 at d 6 postpartum. Cows 
susceptible to fatty liver were subjected for 3 weeks to a 
protocol consisting of feed restriction and dietary 1,3-
butanediol beginning at d 14 postpartum, which induced 
fatty liver and ketosis. Normal cows and cows with fatty 
liver were infused with glucagon for 14 d at 0 or 10 mg/d 
beginning at d 21 postpartum. Composite milk samples 
were obtained at d 20, 22, 34, and 36 postpartum and 
analyzed for milk protein and amino acid composition. Fatty 
liver decreased milk yield but had little effect on milk 
protein and amino acid composition except for increasing 
the proportion of glycosylated κ-casein. Intravenous 
glucagon decreased total milk protein concentrations and the 
proportion of α–lactalbumin and increased the proportion of 
glycosylated κ-casein, total κ-casein, and αS2-casein. 
Intravenous glucagon had little effect on milk amino acid 
composition. Our results suggest that milk protein and 
amino acid composition are under tight concomitant 
hormonal control and are affected little by changes in amino 
acid availability and/or insulin to glucagon ratio. 
 
Introduction 
 Our group showed previously that continuous 
intravenous infusions of glucagon for 14 days can cure fatty 
liver and ketosis. Fatty liver is a major metabolic disease 
that costs U.S. dairy farmers millions of dollars. Glucagon 
increases glucose availability for early lactation cows by 
promoting the release and use of gluconeogenic precursors 
for gluconeogenesis, e.g., deamination of free amino acids 
in the blood. As a result, less amino acids are available for 
extraction by the mammary gland and the milk protein 
content is decreased. The availability of individual amino 
acids for extraction is not equally limited because leucine 
and lysine cannot be used as gluconeogenic precursors. 
 Altering the milk protein composition can improve the 
physical and manufacturing properties of dairy products; 
however, little is known about how to change milk protein 
composition. Insulin and casein infusions increase and 
atropine infusions decrease total protein content but have 
little effect on milk protein composition. Infusion or feeding 
rumen-protected individual amino acids does not 
consistently alter milk protein composition. Therefore, the 
question for this study was: How does intravenous glucagon 
affect the milk protein and amino acid composition?  
 
Materials and Methods 
 On the basis of their body condition score and their 
history of ketosis, multiparous Holstein cows (n=25) at the 
Iowa State University Teaching Herd in Ames were divided 
into normal or susceptible to fatty liver. To induce fatty 
liver, cows (n=11) with a history of ketosis or a body 
condition score of at least 3.5 were fed 5-6 kg of cracked 
corn daily in addition to their dry cow ration for 30 d prior 
to expected calving, whereas normal cows received only 
their dry cow ration. At day 6 postpartum, a liver sample 
was collected by puncture biopsy and analyzed for total 
lipids, triacylglycerol, and glycogen.  Cows (n=11) with a 
ratio of liver triacylglycerol to glycogen greater than 2.0 
started at d 14 postpartum on a feed restriction (80% of 
NRC recommendation) and dietary 1,3-butanediol (0.25-1.4 
L/d) protocol to induce persistent ketonemia and 
hypoglycemia for the next three weeks.  
1. Normal Glucagon: Starting at d 21 postpartum, cows 
(n=8) received intravenously 10 mg/d glucagon dissolved in 
0.15 M NaCl through catheters at 20.83 mg/L and 20 mL/h 
continuously for 14 days. 
2. Susceptible Glucagon: Starting at d 14 postpartum, cows 
(n=7) were on the ketosis induction protocol for 3 weeks. 
Starting at d 21 postpartum, cows received intravenously 10 
mg/d glucagon dissolved in 0.15 M NaCl through catheters 
at 20.83 mg/L and 20 mL/h continuously for 14 days. 
3. Normal Saline: Starting at d 21 postpartum, cows (n=6) 
received intravenously 20 mL/h 0.15 M NaCl continuously 
for 14 days. 
4. Susceptible Saline: Starting at d 14 postpartum, cows 
(n=4) were on the ketosis induction protocol for 3 weeks. 
Starting at d 21 postpartum, cows received intravenously 20 
mL/h of 0.15 M NaCl continuously for 14 days. 
 Composite milk samples from cows were collected one 
day prior and after the beginning and end of the infusion 
period, respectively (d 20, 22, 34, and 36 postpartum). Milk 
samples were sent refrigerated at 4°C to Dairy Lab Services 
(Dubuque, IA) to be analyzed for fat, protein, and lactose by 
Iowa State University Animal Industry Report 2008 
 
mid-infrared spectrophotometry (Milk-O-Scan 203, Foss 
Food Technology Corp., Eden Prairie, MN) and for SCC by 
using a Fossomatic 90 (Foss Food Technology Corp.). 
Concentrations of the casein proteins αS1-casein (αS1–CN), 
β-casein (β-CN), κ-casein (κ-CN), and αS2-casein (αS2-CN) 
and the whey proteins β-lactoglobulin (β–LG) and α-
lactalbumin (α–LA) were determined by reversed-phase 
high performance liquid chromatography (RP-HPLC). After 
acid hydrolysis of milk samples, the amino acid 
composition of milk was determined by RP-HPLC. 
 Data were analyzed statistically by using mixed models 
procedures. The fixed effects in the model were time 
postpartum (d 20, 22, 34, and 35), treatment (normal 
glucagon, susceptible glucagon, normal saline, susceptible 
saline), and the interaction of time with treatment. A 
completely unrestricted variance-covariance matrix was 
used to account for correlations between samples from the 
same cow. Effects of intravenous glucagon were determined 
by using a two-sided t-test comparing the milk protein and 
amino acid composition during vs. before and after the 
infusion period. Effects of fatty liver were determined by 
comparing normal vs. susceptible cows. Figure 1 shows 
least squares means and their standard errors. 
 
Results and Discussion 
 Intravenous glucagon did not affect milk yield (Figure 
1A); however, it decreased protein content in milk by 0.45 ± 
0.04% (P < 0.0001; Figure 1B). The decrease in protein 
content was not altered by fatty liver and ketosis induction. 
Intravenous glucagon resulted in small but highly 
significant changes in milk protein composition. The 
proportion of glycosylated κ-CN and total κ-CN decreased 
by 1.21 ± 0.14% (P < 0.0001; Figure 1C) and 1.81 ± 0.42% 
(P = 0.004; Figure 1D) of total milk protein, respectively.  
Furthermore, intravenous glucagon increased the proportion 
of αS2-CN by 1.93 ± 0.49% (P = 0.0007; Figure 1E) and 
decreased the proportion of α–LA 0.90 ± 0.34% (P = 0.02; 
Figure 1F). No significant changes in milk amino acid 
composition by intravenous glucagon were observed. 
 The lack of significant changes in milk amino acid 
composition was somewhat surprising, as intravenous 
glucagon has been reported to alter the composition of 
plasma amino acids. Our results would suggest that plasma 
amino acid availability affect milk protein content but has 
limited influence on milk protein composition. Similar 
findings have been reported for atropine infusion, which is 
believed to act at least partly through decreased insulin 
concentrations. In our study, insulin concentrations were not 
decreased by intravenous glucagon, which suggest that the 
ratio of insulin to glucagon might affect milk protein 
content. 
 The changes in milk protein composition were rather 
small, which suggests that intravenous glucagon does not 
strongly alter milk protein composition. Similarly to our 
results, atropine infusion decreased concentrations of α–LA 
in milk the strongest and decreased concentrations of αS–CN 
and κ-CN in milk the least. Our results suggest a tight 
concomitant hormonal control of milk protein synthesis, 
which allows only minor changes in milk protein 
composition. 
 Fatty liver and ketosis decreased milk production 
(Figure 1A) but had little effect on milk protein content and 
composition. The only exception is the proportion of 
glycosylated κ-CN in total milk protein, which was 1.50 ± 
0.36% (P = 0.0006; Figure 1C) higher in cows with fatty 
liver. Our results suggest that the proportion of glycosylated 
κ-CN is controlled at least partly independently of other 
milk protein fractions.  The post-translational glycosylation 
of κ-CN is a potential molecular target for the independent 
control. 
 
Conclusion 
 Intravenous glucagon decreases milk protein content 
but results in little changes in milk protein and amino acid 
composition. Therefore, we conclude that milk protein and 
amino acid composition are under tight concomitant 
hormonal control and are affected little by changes in amino 
acid availability and/or insulin to glucagon ratio. 
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Figure 1. Changes in A) milk yield, B) total protein content, C) proportion of glycosylated κ-CN, D) proportion of 
total κ-CN, E) proportion of αS2-CN, and F) proportion of α-LA in Holstein dairy cows in response to fatty liver and 
ketosis induction and/or intravenous glucagon at 10 mg/d for 14 days. 
 
